191 related articles for article (PubMed ID: 35786103)
1. Trends in
Park SO; Yeo I
Ann Med; 2022 Dec; 54(1):1851-1858. PubMed ID: 35786103
[TBL] [Abstract][Full Text] [Related]
2. Clostridioides difficile infection in US hospitals: a national inpatient sample study.
Ramai D; Dang-Ho KP; Lewis C; Fields PJ; Ofosu A; Barakat M; Aamar A; Ofori E; Lai J; Lanke G; Dhaliwal A; Reddy M; Gasperino J
Int J Colorectal Dis; 2020 Oct; 35(10):1929-1935. PubMed ID: 32556651
[TBL] [Abstract][Full Text] [Related]
3. The outcomes of Clostridioides difficile infection in inpatient liver transplant population.
Amjad W; Qureshi W; Malik A; Singh R; Jafri SM
Transpl Infect Dis; 2022 Feb; 24(1):e13750. PubMed ID: 34695277
[TBL] [Abstract][Full Text] [Related]
4. The rise of Clostridioides difficile infections and fall of associated mortality in hospitalized advanced cirrhotics.
Rosenblatt R; Mehta A; Cohen-Mekelburg S; Shen N; Snell D; Lucero C; Jesudian A; Fortune B; Crawford CV; Kumar S
Liver Int; 2019 Jul; 39(7):1263-1270. PubMed ID: 30790420
[TBL] [Abstract][Full Text] [Related]
5. The burden of Clostridioides difficile on COVID-19 hospitalizations in the USA.
Sohal A; Chaudhry H; Singla P; Sharma R; Kohli I; Dukovic D; Prajapati D
J Gastroenterol Hepatol; 2023 Apr; 38(4):590-597. PubMed ID: 36662626
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH.
Patel AH; Pathak GN; Chen A; Greenberg P; Mazzaferro N; Patel A; Mallangada N; Minacapelli CD; Catalano K; Suthar H; Rustgi VK
Ann Hepatol; 2024; 29(4):101510. PubMed ID: 38714224
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of C difficile infection in solid-organ transplant recipients: The National Inpatient Sample (NIS) 2015-2016.
Mahatanan R; Tantisattamo E; Charoenpong P; Ferrey A
Transpl Infect Dis; 2021 Feb; 23(1):e13459. PubMed ID: 32894617
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Clostridioides difficile infection in acute heart failure hospitalizations: insights from the National Inpatient Database.
Duhan S; Taha A; Keisham B; Badu I; Atti L; Hussein MH; Sandhyavenu H; Uppal D; Tantry US; Bliden KP; Tarff A; Ali S; Ali S; Rout A; Gurbel PA
J Hosp Infect; 2024 Mar; 145():129-139. PubMed ID: 38145812
[TBL] [Abstract][Full Text] [Related]
9. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
Mollard S; Lurienne L; Heimann SM; Bandinelli PA
J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis and trends in liver transplant hospitalizations with Clostridium difficile infections: A 10-year national cross-sectional study.
Ali H; Patel P; Pamarthy R; Fatakhova K; Bolick NL; Satapathy SK
Transpl Infect Dis; 2022 Dec; 24(6):e13985. PubMed ID: 36305599
[TBL] [Abstract][Full Text] [Related]
11. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
[TBL] [Abstract][Full Text] [Related]
12. Frailty level at discharge predicts mortality in older patients with Clostridioides difficile more accurately than age or disease severity.
Rubak T; Baunwall SMD; Gregersen M; Hansen TK; Rosenbæk JB; Erikstrup LT; Hvas CL; Damsgaard EMS
Eur Geriatr Med; 2023 Jun; 14(3):583-593. PubMed ID: 37046032
[TBL] [Abstract][Full Text] [Related]
13. Comparative epidemiology of Clostridium difficile infection: England and the USA.
King A; Mullish BH; Williams HRT; Aylin P
Int J Qual Health Care; 2017 Oct; 29(6):785-791. PubMed ID: 29025123
[TBL] [Abstract][Full Text] [Related]
14. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
mBio; 2020 May; 11(3):. PubMed ID: 32371595
[No Abstract] [Full Text] [Related]
15. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer.
de Blank P; Zaoutis T; Fisher B; Troxel A; Kim J; Aplenc R
J Pediatr; 2013 Sep; 163(3):699-705.e1. PubMed ID: 23477996
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection in the USA: incidence and associated factors in revision total knee arthroplasty patients.
Gwam CU; George NE; Etcheson JI; Tarazi JM; Han GR; Griffith KME; Mont MA; Delanois RE
Eur J Orthop Surg Traumatol; 2019 Apr; 29(3):667-674. PubMed ID: 30350019
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Health Outcomes of
Reveles KR; Frei AL; Strey KA; Young EH
Open Forum Infect Dis; 2022 Sep; 9(9):ofac441. PubMed ID: 36092824
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital.
Khanafer N; Vanhems P; Bennia S; Martin-Gaujard G; Juillard L; Rimmelé T; Argaud L; Martin O; Huriaux L; Marcotte G; Hernu R; Floccard B; Cassier P; Group S
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299978
[No Abstract] [Full Text] [Related]
19. Hospital acquired Clostridioides difficile infection and risk factors for severity in a university hospital: A prospective study.
Bilgin H; Sayın E; Gürün HP; Tükenmez-Tigen E; Ülger Toprak N; Korten V
Am J Infect Control; 2020 Dec; 48(12):1426-1430. PubMed ID: 32522607
[TBL] [Abstract][Full Text] [Related]
20. Clostridioides difficile Infections in Inpatient Pediatric Oncology Patients: A Cohort Study Evaluating Risk Factors and Associated Outcomes.
Willis DN; Huang FS; Elward AM; Wu N; Magnusen B; Dubberke ER; Hayashi RJ
J Pediatric Infect Dis Soc; 2021 Apr; 10(3):302-308. PubMed ID: 32766672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
